eric lawitz

Explore academic connections and research related to this keyword

132

Views

3

Total Connections

Search More Keywords

Related Articles & Bibliographies

1

Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials

Jacobson IM;Lawitz E;Gane EJ;Willems BE;Ruane PJ;Nahass RG;Borgia SM;Shafran SD;Workowski KA;Pearlma...

2017 gastroenterology 265 views

2

Efficacy and safety of 12 weeks versus 18 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin for hepatitis C virus genotype 1 infection in previously untreated patients with cirrhosis and patients with previous null response with or without cirrhosis (C-WORTHY): a randomised, open-label phase 2 trial

Lawitz E;Gane E;Pearlman B;Tam E;Ghesquiere W;Guyader D;Alric L;Bronowicki JP;Lester L;Sievert W;Gha...

2015 Lancet (London, England) 245 views

3

Sofosbuvir for previously untreated chronic hepatitis C infection

Lawitz E;Mangia A;Wyles D;Rodriguez-Torres M;Hassanein T;Gordon SC;Schultz M;Davis MN;Kayali Z;Reddy...

2013 The New England journal of medicine 326 views

Related Journals

No Journals Found

No journals are currently associated with this keyword.

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

hepatitis c National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine adult female male adolescent aged middle aged young adult 80 and over Clinical Trial Phase III